The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines
Abstract
We conducted a double-blind, placebo-controlled trail in which 40 patients who had undergone long-term therapy with benzodiazepines were switched to placebo or to diazepam in a dose approximately equivalent to their usual dose of the benzodiazepine; the dose of diazepam was then tapered during an eight-week period. Patients were assessed clinically and psychologically and had weekly sessions of behavioral therapy. The subjects who received placebo had more symptoms, assessed their symptoms as more severe, and stopped taking the study drug at a higher rate than those receiving the tapering doses of diazepam. The subjects in the placebo group also had symptoms shortly after being switched to placebo, whereas those in the diazepam group had symptoms much later. Some withdrawal symptoms were distinct from those of anxiety (e.g., tinnitus, involuntary movement, and perceptual changes). Withdrawal symptoms occurred earlier in patients who had received short-acting benzodiazepines than in those who had received long-acting benzodiazepines. Symptoms gradually disappeared over a four-week period in both the placebo and the diazepam groups. Serial determination of plasma benzodiazepine concentrations was a useful way to assess compliance, treatment outcome, and relapse during withdrawal. We conclude that a clinically important, mild, but distinct withdrawal syndrome occurs after discontinuation of long-term therapeutic use of benzodiazepines.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“but concerns [13] have remained about supersensitivity psychosis [9].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [13]
In the citing paper
“Second-generation antipsychotics (SGAs) decreased the prevalence of drug-induced movement disorders, including tardive dyskinesia [13]”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [13]
In the citing paper
“Most common withdrawal symptoms in placebo group 4 wk post-d/c were anxiety, insomnia, fear, headache, tension, tremor, sensory disturbance, fatigue, sweating, and difficulty concentrating.”
From Long-term neurological consequences following benzodiazepine exposure: A scoping review (2025) · cites this paper as [30]
In the citing paper
“The population of benzodiazepine patients has been described as a “diagnostically heterogenous group,” which aligns with these results [30,36,40,55,59,65,67].”
From Long-term neurological consequences following benzodiazepine exposure: A scoping review (2025) · cites this paper as [30]
In the citing paper
“The most common indications for benzodiazepine use in these studies were insomnia [30,36,40,55,59,67], generalized anxiety disorder [32,34,45,50,54,65,68], and anxiety with or without panic attacks [30,36,48,54,59,65]”
From Long-term neurological consequences following benzodiazepine exposure: A scoping review (2025) · cites this paper as [30]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604
Statistical Methods for Survival Data Analysis.
Lachenbruch, P. A., & Lee, E. T. (1993) · Journal of the American Statistical Association · doi:10.2307/2290742 · Cited by 2,845
Assessment of social adjustment by patient self report.
Weissman, M. M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090101010 · Cited by 1,782
Selective antagonists of benzodiazepines
Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonetti, E. P., Cumin, R., Schaffner, R., & Haefely, W. (1981) · Nature · doi:10.1038/290514a0 · Cited by 1,232
TOLERANCE TO, AND DEPENDENCE ON, SOME NON-OPIATE PSYCHOTROPIC DRUGS
Kalant, H., LeBlanc, A. E., & Gibbins, R. J. (1971) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06888-7 · Cited by 766
Current Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090705 · Cited by 451
Withdrawal from long-term benzodiazepine treatment
Petursson, H., & Lader, M. H. (1981) · BMJ · doi:10.1136/bmj.283.6292.643 · Cited by 367
Withdrawal reactions from chlordiazepoxide (?Librium?)
Hollister, L. E., Motzenbecker, F. P., & Degan, R. O. (1961) · Psychopharmacologia · doi:10.1007/bf00429621 · Cited by 340
Benzodiazepine withdrawal symptoms and propranolol
TYRER, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92861-0 · Cited by 297
Research works printed but not linked: 5
- Petursson H, Lader M. Dependence on tranquilizers. New York: Oxford University Press, 1984.
- Kapur, 1975, Clin Chem, 21, 947
- Spielberger CD, Gorsuch RL, Lushene RE, Bagg PR, Jacobs GA. Manual for state-trait anxiety inventory. Palo Alto, Calif.: Consulting Psychologists Inc. Press, 1970.
- Paitich, 1970, Ontario Psychol, 2, 304
- Balter, 1984, Curr Med Res Opin, 8, 5
Cited by
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
Benzodiazepine use, abuse, and dependence.
O’Brien, C. P. (2005) · PubMed · Cited by 534
An integrative model of tinnitus based on a central gain controlling neural sensitivity
Noreña, A. J. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.11.003 · Cited by 452
The effects of chronic antidepressant treatment in an animal model of anxiety
Bodnoff, S., Suranyi-Cadotte, B., Aitken, D., Quirion, R., & Meaney, M. (1988) · Psychopharmacology · doi:10.1007/bf00181937 · Cited by 437
“Yet, despite their widespread use, there is a growing concern over the adverse effects associated with long term use of benzodiazepines (Owens and Tyrer 1983; Ashton 1984; Busto et al. 1986).”
BackgroundRickels, K. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820230054005 · Cited by 412
Metadata
- Authors
- Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K.
- ORCID
- Sellers, Edward M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1986-10-02
- Volume
- 315
- Issue
- 14
- Pages
- 854-859
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2335780156
- Semantic Scholar
- db4d4a5d8851fdefa3753458ceea4395d3d71e9e
- Cited by
- 369
- References
- 38
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 7 · 2021: 2 · 2020: 9 · 2019: 3 · 2018: 9 · 2017: 6 · 2016: 4 · 2015: 4 · 2014: 6 · 2013: 5 · 2012: 10
- FWCI
- 18.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- benzodiazepine withdrawal, diazepam, withdrawal symptoms, tinnitus, involuntary movements, perceptual change, short-acting benzodiazepines, long-acting benzodiazepines, medication adherence, relapse, behavior therapy
- MeSH terms
- Adolescent, Adult, Aged, Anxiety, Benzodiazepines, Diazepam, Double-Blind Method, Female, Flurazepam, Humans, Long-Term Care, Lorazepam, Male, Middle Aged, Oxazepam, Patient Compliance, Placebos, Substance Withdrawal Syndrome, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines. https://app.cochat.ai/papers/10.1056/nejm198610023151403
- The paper
- Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986). Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines. New England Journal of Medicine. https://doi.org/10.1056/nejm198610023151403
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.